User: OPTILAB CHUM
Translational research bridges the gap between laboratory science and application in healthcare. To ensure the reliability of these discoveries, they must be validated according to strict standards. In our project, we want to create an infrastructure to help doctors identify the best treatment to propose to each patient. First, we will accredit the molecular pathology platform of the CHUM Research Center according to the same standards as CHUM laboratories. Next, we propose to set up a rigorous and efficient process whereby the tumors of twenty ovarian cancer patients will be prepared and analyzed using advanced genetic sequencing technologies. We will analyze and combine these results with other information on each patient and existing knowledge to create a clinical report. This recommendation will be discussed with the patient, to ensure that the chosen treatment also meets her preferences and values. With time, this will enable us to propose most effective and least harmful treatment for these patients. This pilot will serve as a means to extend this type of approach to other cancer types.